Dextromethorphan and Bupropion Sustained-Release Tablets for major depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Apr 2025: Trial started, NCT06958692
  2. 6 May 2025: Trial registered, NCT06958692

The trials

NCT06958692: A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder

State
Under way
Phase
Phase 3
People
388 planned
Started
11 Apr 2025
Primary completion
30 Sep 2026
Arms
Dextromethorphan and Bupropion
Results
None posted
  1. 11 Apr 2025: Trial started
  2. 6 May 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.